Breathing life back into Empty Nose Syndrome with MSCs

Mesenchymal Stem Cell therapies provide a path toward relief and restoration, helping you in regaining balance, comfort, and the freedom of effortless breathing.

About Empty Nose Syndrome

Empty nose syndrome (ENS) is a rare medical condition that affects the nose and nasal passages. It occurs when the turbinates, small bony structures in the nose that help to moisturize and filter the air we breathe, are removed or significantly reduced in size. This can happen as a result of certain nasal surgeries, such as turbinectomy or septoplasty. The removal of the turbinates can result in a feeling of “emptiness” or a sense of a wide-open nasal cavity, which can lead to symptoms such as dryness, congestion, difficulty breathing, and a decreased ability to smell. Some people with ENS also experience a range of other symptoms, including fatigue, headaches, and anxiety.

The Symptoms

Empty Nose Syndrome (ENS) symptoms can cause a range of symptoms, which can vary from person to person. Some of the most common symptoms of ENS include:

  • Nasal dryness and irritation:
    Many people with ENS describe a sensation of dryness and irritation in the nasal passages, which can make it difficult to breathe comfortably.

  • Difficulty breathing:
    ENS can cause a feeling of congestion or obstruction in the nasal passages, making it difficult to breathe through the nose.

  • Decreased sense of smell:
    ENS can affect the olfactory nerves, which can lead to a decreased sense of smell or even complete loss of smell

  • Fatigue:
    Some people with ENS experience fatigue or tiredness, which may be related to the difficulty breathing and disrupted sleep patterns

  • Anxiety or depression:
    Living with ENS can be challenging, and some people may experience anxiety, depression, or other emotional symptoms as a result

It’s important to note that not everyone with ENS will experience all of these symptoms, and the severity of symptoms can also vary from person to person.

The Causes

Empty Nose Syndrome (ENS) is a rare and often underdiagnosed condition that affects the nasal passages. It occurs primarily after a surgical procedure called turbinate reduction or turbinectomy, which aims to improve airflow by reducing the size of the nasal turbinates. Turbinates are structures in the nose that help to warm, humidify, and filter the air we breathe. While the exact cause of ENS is not fully understood, several factors are thought to contribute to its development:

  • Over-aggressive turbinate reduction:
    Removing too much turbinate tissue can lead to ENS. This disrupts the balance of the nasal environment, causing symptoms like dryness, crusting, and a sense of nasal obstruction.

  • Altered nasal airflow:
    After turbinate reduction, the altered nasal airflow pattern can cause turbulent airflow, leading to the feeling of nasal obstruction and difficulty breathing, even though the nasal passages may be physically open.

  • Loss of nasal function:
    The reduced turbinate tissue can result in a diminished ability to warm, humidify, and filter the air we breathe, leading to the various symptoms of ENS.

  • Nerve damage:
    Surgical intervention can inadvertently damage nerves responsible for sensation in the nasal passages, contributing to the development of ENS symptoms.

  • Psychological factors:
    Some researchers believe that psychological factors such as anxiety, depression, or heightened sensitivity to physical sensations may play a role in the development or exacerbation of ENS symptoms.

The Consequences

Empty Nose Syndrome (ENS) can have a significant impact on an individual’s quality of life due to the chronic and often debilitating symptoms it causes. Some of the consequences and side effects of ENS include:

  • Nasal dryness:
    The loss of normal turbinate function can lead to persistent nasal dryness, making the nasal passages more prone to irritation, inflammation, and infection.

  • Crusting and bleeding:
    The chronic dryness and irritation can result in the formation of crusts and nasal sores, which may cause frequent bleeding.

  • Breathing difficulties:
    Despite having an open nasal passage, individuals with ENS may experience a paradoxical sensation of nasal obstruction or difficulty breathing due to altered airflow patterns.

  • Decreased sense of smell:
    The changes in the nasal environment and airflow can lead to a diminished sense of smell, known as hyposmia or anosmia.

  • Sleep disturbances:
    Breathing difficulties, discomfort, and dryness associated with ENS can disrupt sleep, leading to insomnia or other sleep disorders.

  • Fatigue:
    The combination of sleep disturbances, breathing difficulties, and constant discomfort can contribute to chronic fatigue and a reduced ability to function in daily life.

  • Anxiety and depression:
    The chronic nature of ENS symptoms and the impact on daily life can lead to feelings of anxiety, depression, and frustration, further affecting an individual’s overall well-being.

  • Social and professional consequences:
    The physical and emotional challenges associated with ENS can lead to difficulties in social interactions and professional performance, potentially resulting in isolation and reduced work productivity.

  • Multiple treatments:
    Individuals with ENS may undergo various treatments, including medications, saline rinses, and in some cases, additional surgical procedures, which can have their own side effects and risks

Can’t wait to feel like yourself again?

How?

It’s easier than you think. Discover the world’s most advanced Stem Cell and Exosomes treatment. Reach out to us — we’re here for you and happy to answer any questions you may have.

Where?

Como (Italy)
Milano (Italy)
Rome (Italy)
Varese (Italy)
Falciano (RSM)

The Treatment

Currently, treatment for ENS typically involves symptom management, such as the use of nasal sprays, humidifiers, and saline nasal irrigations. In some cases, surgical reconstruction of the nasal tissues may be necessary. In some cases, surgical reconstruction of the turbinates or nasal tissues may be necessary. However, the success of these treatments can vary, and some people with ENS may continue to experience symptoms despite treatment.

TRADITIONAL TREATMENTS

Some of traditional treatments that may help alleviate the symptoms of ENS include:
  • Nasal saline irrigations to rinse the nasal passages and help reduce dryness and congestion.
  • Nasal sprays and ointments to help moisturize and lubricate the nasal passages and reduce dryness and congestion.
  • Humidifiers can help to increase the moisture content in the air and reduce dryness and irritation.
  • Surgical reconstruction
  • Psychological support to help cope with the condition.

MSCs TREATMENT

There is currently evidence to suggest that stem cell therapy can effectively treat empty nose syndrome (ENS). Stem cells have the ability to differentiate into many different cell types, and this property makes them potentially useful in tissue repair and regeneration. When used for reconstructive purposes, stem cells can help to replace damaged or diseased tissue, promote healing, and stimulate the growth of new tissue.

Some specific properties of stem cells that make them useful for reconstructive purposes include:

  • Self-renewal: Stem cells are capable of dividing and producing more stem cells, allowing for the potential to generate large quantities of cells for use in tissue repair.
  • Differentiation: Stem cells can differentiate into many different types of cells, such as muscle cells, nerve cells, and bone cells. This property allows them to be used for a wide range of tissue repair applications.
  • Secretion of growth factors: Stem cells can secrete growth factors and other signaling molecules that can promote tissue regeneration and healing.
All these properties make stem cells a promising therapeutic option for the treatment of Empty Nose Syndrome (ENS).

We offer a range of treatments for various medical conditions, including Empty Nose Syndrome (ENS). Our approach to treating ENS involves the use of autologous tissue engineering, which involves using the patient’s own cells to regenerate the damaged tissues in the nasal passages.

Our treatment involves harvesting stem cells from the patient’s fat, processing and growing these cells in a laboratory, and then reintroducing the cells into the patient’s nasal passages to regenerate the damaged tissues. The goal of the treatment is to restore the normal function and structure of the nasal passages, which can alleviate the symptoms of ENS.

Stem Cell Procedure

Let’s clarify with accurate information:

Stem Cells obtained from a fat sample require at least two weeks of processing before they can be used; otherwise, the treatment is ineffective and potentially harmful:

  • Fat that is harvested and manipulated for use in the same session is both useless and harmful.
  • There are no Stem Cells in the blood, so treatments claiming to use stem cells extracted from blood are not scientifically valid. The Stem Cells used to treat hematological diseases are found in the bone marrow, not in the blood.
  • The hematopoietic stem cells found in umbilical cord blood are useful for treating blood disorders, but not for counteracting the aging processes of the human body

The Stem Cell Source

Mesenchymal stem cells are the same regardless of whether they are derived from Adipose Tissue or Umbilical Cord Tissue. The only difference lies in their biological age, which reflects the age of the tissue of origin.

Adipose Tissue Derived Stem Cells 

The treatment requires a fat collection, stem cell extraction, and expansion. The entire process takes approximately 2–3 weeks. Therefore, from the moment of fat harvesting, a waiting period of 2–3 weeks is necessary before the treatment can be performed.

Umbilical Cord Tissue derived Stem Cells

The treatment does not require fat harvesting and can be performed within 2–3 days of the request.

Contact us Today

Why?

Because you deserve to feel great again. To feel like yourself. The solution exists — it’s real, and it starts with your choice.

Where?

Como (Italy)
Milano (Italy)
Rome (Italy)
Varese (Italy)
Falciano (RSM)

Stromal Vascular Fraction (SVF) VS Mesenchymal Stem Cells (MSC)

In the regenerative medicine landscape, many providers offer therapies labeled as "Stem Cell treatments" that utilize Stromal Vascular Fraction (SVF)—a heterogeneous mix of cells extracted from adipose tissue. While SVF contains some Stem Cells, it also includes various other cell types, leading to variability in treatment outcomes.
At our Clinic, we prioritize precision and efficacy by exclusively using Mesenchymal Stem Cells (MSCs). These are meticulously isolated and expanded in controlled laboratory settings, ensuring a pure, potent, and standardized cell population. This approach enhances the therapeutic potential and consistency of our treatments.

Standard Product and Therapy

MSC
YES, A pharma-grade product derived from a cell isolation and culture process, subject to strict quality control procedures

SVF
NO, Composition varies based on the collection site, the patient’s biological age, the digestion technique used, and several other factors.

Cellular Homogeneity

MSC
YES, Isolated and phenotyped cells

SVF
NO, Heterogeneous cell population

Concentration of MSC

MSC
100%

SVF
Between 0,001% and 0,01% of the total cells within

MSC per 10ml FAT

MSC
>100.000.000 after expansion

SVF
Around 9.000

Microphages per 10ml FAT

MSC
0 - Eliminated through isolation of MSCs

SVF
>400.000

Side Effects

MSC
NO

SVF
YES, often unpredictable, usually mediated by inflammatory processes caused by the macrophage population or potential bacterial contamination

Dosage

MSC
VARIOUS DOSAGES AVAILABLE
10-200 millions of MSC (based on indications)

SVF
SINGLE DOSAGE
not tailored to treatment

Safety

MSC
Pharma-grade production process, subjected to quality controls that ensure product sterility and biological safety

SVF
The production process is not monitorable and not subject to quality and biological safety controls

Treatments from 1 fat Collection

MSC
≥10

SVF
1

Phenotyping

MSC
YES

SVF
NO

Cellular Composition

MSC
Mesenchymal Stem Cells

SVF
Pericytes, Macrophages, Endothelial Cells, Mesenchymal Stem Cells, Adipocytes, Lymphocytes, Fibroblasts

Quality Control

MSC
Endotoxins, Mycoplasma, Anaerobic/Aerobic Bacteria, Viruses, Phenotype

SVF
None

Production Time

MSC
2-4 Weeks

SVF
1 hour

FDA Approval

MSC
YES (Ryoncil 18-12-2024)

SVF
NO

EMA Approval

MSC
YES (Alofisel, Spherox, Ryoncil)

SVF
NO

Usage

MSC
Autologous and Allogenic Localized and Systemic

SVF
Strictly Autologous, Homologous, and Localized

    POWERED BY

    BioScience Institute

    As the world’s leading center of Stem Cell and Regenerative Medicine, Bioscience offers unparalleled service and treatments, unique only to it. Bioscience offers the most advanced personalized expanded adipose derived Stem Cell therapies across Europe – including Rome, Milan, and San Marino, and the Middle East, including Dubai.

    The team at Bioscience Institute does not believe in using invasive surgeries when they can be partially replaced by cell biology. Therefore, they have designed an alternative method of extracting stem cells from adipose tissue. As a distinctive and versatile offering, adipose tissue provides an effective solution to all of Bioscience regenerative services, ranging from to hair loss treatments, to skin aging, to body reshaping treatments.

    Bioscience Institute Vision

    The beauty of regenerative medicine therapies and Stem Cell treatments comes from the ability to use your own body to help heal and enhance your well-being through living body tissue. Bioscience Institute’s vision is based on using this most effective and advanced Stem Cell treatments that is based on cell biology and Exosomes to help amplify our natural healing process in the areas it is needed most or take over the function of damaged tissue altogether.

    Stem cells verified treatments

    With the ability to develop methods to regrow, repair, or replace damaged cells and tissues, using Stem Cell & regenerative medicines provides a natural method of treatment that is less traumatic to the body and more effective than other more invasive treatments and surgeries. The stem cell therapies provided by Bioscience Institute are verified in Europe and the Middle East by scientific evidence of increased safety and efficiency than any other treatment method.

    Scientific Research

    The Bioscience’s profits are consistently reinvested into developing research. Avoiding a flashy commercial profile allows us to concentrate on using investments to create better treatments and ultimately help clients globally. Due to this commitment, Bioscience Institute has instigated important scientific collaborations with leading universities, pioneering procedures and methods around cell products.

    Bioscience Cell Factory and Clinic in Dubai, San Marino, Italy & Switzerland

    Bioscience Institute is the first and only GMP-certified Clinic in the Middle East and Europe, offering stem cell treatments with the most advanced personalized autologous cell therapies worldwide.
    Offering a unique service and treatment sets it apart from any form of competition and allows it to give clients the care, attention, and treatment they deserve.

    • Bioscience Clinics in the Middle East and Europe include a fully equipped facility needed to carry out any treatments offered, whether Stem Cell treatments or banking.
    • Bioscience Laboratory is a dedicated Cell Banking Factory used to store and expand Adipose-Derived Cells and Fibroblasts to help ensure that the clients’ needs can always and easily be catered to.